Benjamin Pradere Selected Research

Benjamin Pradere Research Topics

Disease

54	Carcinoma (Carcinomatosis) 03/2024 - 01/2020
46	Neoplasms (Cancer) 05/2024 - 07/2018
45	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2020
34	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 08/2020
25	Non-Muscle Invasive Bladder Neoplasms 01/2024 - 01/2020
16	Neoplasm Metastasis (Metastasis) 05/2024 - 06/2018
16	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 06/2018
8	Inflammation (Inflammations) 03/2024 - 09/2021
7	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2023 - 07/2018
7	Lymphatic Metastasis 05/2023 - 11/2021
5	Wounds and Injuries (Trauma) 01/2023 - 01/2020
3	Margins of Excision 11/2023 - 01/2018
3	Disease Progression 10/2023 - 01/2021
3	Infections 01/2021 - 01/2019
3	COVID-19 01/2021 - 10/2020
2	Diabetes Mellitus 11/2023 - 12/2017
2	Erectile Dysfunction 08/2023 - 04/2021
2	Urologic Neoplasms (Urological Cancer) 01/2023 - 11/2022
2	Hemorrhage 01/2022 - 08/2019
2	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 09/2021
2	Lower Urinary Tract Symptoms 11/2021 - 09/2021
2	Anemia 01/2021 - 01/2021
2	Febrile Neutropenia 01/2021 - 01/2021
2	Fatigue 01/2021 - 01/2021
1	Cystitis 03/2024
1	Venous Thromboembolism 03/2024
1	Hypertension (High Blood Pressure) 11/2023
1	Necrosis 11/2023
1	Pain (Aches) 08/2023

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2020
13	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
8	GlobulinsIBA 03/2022 - 01/2021
7	AndrogensIBA 04/2024 - 01/2021
7	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 11/2020
7	AlbuminsIBA 01/2023 - 01/2021
6	Docetaxel (Taxotere)FDA Link 04/2024 - 01/2022
6	Serum AlbuminIBA 10/2021 - 01/2021
5	NivolumabIBA 04/2024 - 01/2022
5	Hormones (Hormone)IBA 04/2024 - 01/2022
5	Gemcitabine FDA Link 05/2023 - 01/2021
4	Cisplatin (Platino)FDA LinkGeneric 05/2023 - 01/2021
4	PlatinumIBA 02/2023 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 11/2023 - 08/2019
3	pembrolizumabIBA 10/2023 - 01/2022
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2023 - 01/2020
3	darolutamideIBA 01/2023 - 11/2020
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 11/2020
3	enzalutamideIBA 12/2022 - 11/2020
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2021
2	cabozantinibIBA 04/2024 - 10/2023
2	IpilimumabIBA 04/2024 - 10/2023
2	5-alpha Reductase InhibitorsIBA 10/2023 - 10/2023
2	Carboplatin (JM8)FDA LinkGeneric 05/2023 - 11/2022
2	C-Reactive ProteinIBA 01/2023 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2020
2	apalutamideIBA 12/2022 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2020
2	AntigensIBA 01/2022 - 12/2020
2	ClaudinsIBA 01/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2021
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021 - 12/2020
2	Alanine Transaminase (SGPT)IBA 06/2021 - 12/2020
2	dimemorfan (AT 17)IBA 03/2021 - 04/2020
2	AerosolsIBA 01/2021 - 01/2021
2	mesoglycanIBA 12/2020 - 11/2020
1	GlycosaminoglycansIBA 03/2024
1	Hyaluronic Acid (Hyaluronan)IBA 03/2024
1	PotassiumIBA 03/2024
1	IonsIBA 03/2024
1	ChondroitinIBA 03/2024
1	Kallikreins (Kallikrein)IBA 11/2023
1	Phosphodiesterase 5 InhibitorsIBA 08/2023
1	Cholinesterases (Cholinesterase)IBA 07/2023
1	ElementsIBA 06/2023

Therapy/Procedure

50	Therapeutics 05/2024 - 01/2019
37	Cystectomy 04/2024 - 01/2020
19	Nephroureterectomy 03/2024 - 09/2020
19	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
16	Immunotherapy 04/2024 - 01/2020
15	Neoadjuvant Therapy 01/2024 - 01/2021
14	Nephrectomy 11/2023 - 06/2018
14	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 10/2020
13	Transurethral Resection of Bladder 10/2023 - 01/2021
8	Castration 10/2023 - 11/2020
7	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 01/2021
5	Urinary Diversion (Ileal Conduit) 09/2023 - 11/2020
4	Length of Stay 09/2023 - 01/2018
4	Adjuvant Chemotherapy 12/2022 - 06/2020
4	Radiotherapy 03/2022 - 10/2020
3	Combination Drug Therapy (Combination Chemotherapy) 02/2023 - 01/2021
3	Transurethral Resection of Prostate (TURP) 01/2023 - 07/2018
2	Induction Chemotherapy 03/2024 - 05/2023
2	Enhanced Recovery After Surgery 11/2022 - 11/2020
2	Precision Medicine 01/2022 - 01/2021
2	Minimally Invasive Surgical Procedures 01/2021 - 01/2021
2	Lasers (Laser) 02/2019 - 07/2018
1	Combined Modality Therapy 05/2024
1	Patient Readmission 03/2024
1	Traction 08/2023